BIBLIOGRAFÍA Conclusiones ______________________________________________________________________ 233

Conclusiones
______________________________________________________________________
233
BIBLIOGRAFÍA

Conclusiones
______________________________________________________________________
234Conclusiones
______________________________________________________________________
234

Bibliografía
______________________________________________________________________
239
7. BIBLIOGRAFÍA
Alcorta, D. A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., and Barrett, J. C. (1996).
Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative
senescence of normal human fibroblasts. Proc Natl Acad Sci U S A 93, 13742-13747.
Andreassen, P. R., Lacroix, F. B., Lohez, O. D., and Margolis, R. L. (2001). Neither
p21WAF1 nor 14-3-3sigma prevents G2 progression to mitotic catastrophe in human
colon carcinoma cells after DNA damage, but p21WAF1 induces stable G1 arrest in
resulting tetraploid cells. Cancer Res 61, 7660-7668.
Asai, G., Yamamoto, N., Toi, M., Shin, E., Nishiyama, K., Sekine, T., Nomura, Y.,
Takashima, S., Kimura, M., and Tominaga, T. (2002). Pharmacokinetic and
pharmacodynamic study of IST-622, a novel synthetic derivative of chartreusin, by oral
administration in a phase II study of patients with breast cancer. Cancer Chemother
Pharmacol 49, 468-472.
Baek, K. H., Shin, H. J., Yoo, J. K., Cho, J. H., Choi, Y. H., Sung, Y. C., McKeon, F.,
and Lee, C. W. (2003). p53 deficiency and defective mitotic checkpoint in proliferating
T lymphocytes increase chromosomal instability through aberrant exit from mitotic
arrest. J Leukoc Biol 73, 850-861.
Barbisan, L. F., Mello, M. L., Russo, J., and Vidal, B. C. (1999). Apoptosis and
catastrophic cell death in benzo[a]pyrene-transformed human breast epithelial cells.
Mutat Res 431, 133-139.
Barboule, N., Chadebech, P., Baldin, V., Vidal, S., and Valette, A. (1997). Involvement
of p21 in mitotic exit after paclitaxel treatment in MCF-7 breast adenocarcinoma cell
line. Oncogene 15, 2867-2875.
Barceló, F., Pons, J., Petitpierre, E., Barjau, I., and Portugal, J. (1997). Polymorphic
curvature of satellite DNA in three subspecies of the beetle Pimelia sparsa. Eur J
Biochem 244, 318-324.
Baus, F., Gire, V., Fisher, D., Piette, J., and Dulic, V. (2003). Permanent cell cycle exit
in G2 phase after DNA damage in normal human fibroblasts. Embo J 22, 3992-4002.
Beato, M. (1990). Course on DNA-Protein Interaction (Madrid, Spain, Fundación Juan
March -Serie Universitaria-).
Beausejour, C. M., Krtolica, A., Galimi, F., Narita, M., Lowe, S. W., Yaswen, P., and
Campisi, J. (2003). Reversal of human cellular senescence: roles of the p53 and p16
pathways. EMBO J 22, 4212-4222.
Bein, K., Odell-Fiddler, E. T., and Drinane, M. (2004). Role of TGF-E1 and JNK
signaling in capillary tube patterning. Am J Physiol Cell Physiol 287, C1012-C1022.

Bibliografía
______________________________________________________________________
240
Belloc, F., Lacombe, F., Dumain, P., Lopez, F., Bernard, P., Boisseau, M. R., and
Reifers, J. (1992). Intercalation of anthracyclines into living cell DNA analyzed by flow
cytometry. Cytometry 13, 880-885.
Bellorini, M., Moncollin, V., D'Incalci, M., Mongelli, N., and Mantovani, R. (1995).
Distamycin A and tallimustine inhibit TBP binding and basal in vitro transcription.
Nucleic Acids Res 23, 1657-1663.
Bernards, R., Schackleford, G. M., Gerber, M. R., Horowitz, J. M., Friend, S. H.,
Schartl, M., Bogenmann, E., Rapaport, J. M., McGee, T., Dryja, T. P., and et al. (1989).
Structure and expression of the murine retinoblastoma gene and characterization of its
encoded protein. Proc Natl Acad Sci U S A 86, 6474-6478.
Bernstein, C., Bernstein, H., Payne, C. M., and Garewal, H. (2002). DNA repair/pro-
apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection
against carcinogenesis. Mutat Res 511, 145-178.
Black, A. R., Black, J. D., and Azizkhan-Clifford, J. (2001). Sp1 and kruppel-like factor
family of transcription factors in cell growth regulation and cancer. J Cell Physiol 188,
143-160.
Black, A. R., Jensen, D., Lin, S. Y., and Azizkhan, J. C. (1999). Growth/Cell cycle
regulation of Sp1 phosphorylation. J Biol Chem 274, 1207-1215.
Bladier, C., Wolvetang, E. J., Hutchinson, P., de Haan, J. B., and Kola, I. (1997).
Response of a primary human fibroblast cell line to H2O2: senescence-like growth arrest
or apoptosis? Cell Growth Differ 8, 589-598.
Boatright, K. M., Salvesen, G.S. (2003). Mechanisms of caspase activation. Curr Opin
Cell Biol 15, 725-731.
Booser, D. J., and Hortobagyi, G. N. (1994). Anthracycline antibiotics in cancer
therapy. Focus on drug resistance. Drugs 47, 223-258.
Botella, L. M., Sánchez-Elsner, T., Rius, C., Corbi, A., and Bernabéu, C. (2001).
Identification of a critical Sp1 site within the endoglin promoter and its involvement in
the transforming growth factor-E stimulation. J Biol Chem 276, 34486-34494.
Boxer, L. M., and Dang, C. V. (2001). Translocations involving c-myc and c-myc
function. Oncogene 20, 5595-5610.
Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram
quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72,
248-254.
Bree, R. T., Stenson-Cox, C., Grealy, M., Byrnes, L., Gorman, A. M., and Samali, A.
(2002). Cellular longevity: role of apoptosis and replicative senescence. Biogerontology
3, 195-206.

Bibliografía
______________________________________________________________________
241
Briggs, M. R., Kadonaga, J. T., Bell, S. P., and Tjian, R. (1986). Purification and
biochemical characterization of the promoter-specific transcription factor, Sp1. Science
234, 47-52.
Broggini, M., Ponti, M., Ottolenghi, S., D'Incalci, M., Mongelli, N., and Mantovani, R.
(1989). Distamycins inhibit the binding of OTF-1 and NFE-1 transfactors to their
conserved DNA elements. Nucleic Acids Res 17, 1051-1059.
Brown JM, A. L. (2005). The role of apoptosis in cancer development and treatment
response. Nat Rev Cancer 5, 231-237.
Brown, J. M., and Attardi, L. D. (2005). The role of apoptosis in cancer development
and treatment response. Nat Rev Cancer 5, 231-237.
Brown, J. M., and Wouters, B. G. (1999). Apoptosis, p53, and tumor cell sensitivity to
anticancer agents. Cancer Res 59, 1391-1399.
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J.
M., Kinzler, K. W., and Vogelstein, B. (1998). Requirement for p53 and p21 to sustain
G2 arrest after DNA damage. Science 282, 1497-1501.
Burlacu, A. (2003). Regulation of apoptosis by Bcl-2 family proteins. J Cell Mol Med 7,
249-257.
Castedo, M., Perfettini, J. L., Roumier, T., Andreau, K., Medema, R., and Kroemer, G.
(2004a). Cell death by mitotic catastrophe: a molecular definition. Oncogene 23, 2825-
2837.
Castedo, M., Perfettini, J. L., Roumier, T., Valent, A., Raslova, H., Yakushijin, K.,
Horne, D., Feunteun, J., Lenoir, G., Medema, R., et al. (2004b). Mitotic catastrophe
constitutes a special case of apoptosis whose suppression entails aneuploidy. Oncogene
23, 4362-4370.
Chabner, B. A., and Longo, D. L. (2001). Cancer Chemotherapy and Biotherapy:
Principles and Practice, 3rd edn (Philadelphia, PA, Lippincott-Williams & Wilkins).
Chaires, J. B. (1990). Biophysical chemistry of the daunomycin-DNA interaction.
Biophys Chem 35, 191-202.
Chaires, J. B. (1996). Molecular recognition of DNA by daunorubicin. In Advances in
DNA sequence specific agents, L. Hurley, and J. B. Chaires, eds. (Greenwich, CT, JAI
Press Inc.), pp. 141-167.
Chaires, J. B. (1998). Drug-DNA interactions. Curr Opin Struct Biol 8, 314-320.
Chaires, J. B., Fox, K. R., Herrera, J. E., Britt, M., and Waring, M. J. (1987). Site and
sequence specificity of the daunomycin-DNA interaction. Biochemistry 26, 8227-8236.